Point72 Hong Kong LTD Intra Cellular Therapies, Inc. Transaction History
Point72 Hong Kong LTD
- $1.54 Billion
- Q4 2024
A detailed history of Point72 Hong Kong LTD transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Point72 Hong Kong LTD holds 2,840 shares of ITCI stock, worth $374,027. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,840
Previous 6,293
54.87%
Holding current value
$374,027
Previous $460,000
48.48%
% of portfolio
0.02%
Previous 0.03%
Shares
16 transactions
Others Institutions Holding ITCI
# of Institutions
418Shares Held
87.7MCall Options Held
284KPut Options Held
105K-
Vanguard Group Inc Valley Forge, PA9.72MShares$1.28 Billion0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$833 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.13MShares$675 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.25MShares$428 Million1.36% of portfolio
-
Norges Bank Oslo, Q83.21MShares$423 Million0.04% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $12.4B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...